Which option correctly matches a stage with its primary objective in the traditional drug development pipeline?

Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

Which option correctly matches a stage with its primary objective in the traditional drug development pipeline?

This question tests understanding of what each stage in the traditional drug development pipeline is aiming to achieve. In the discovery and preclinical phase, the focus is on identifying and characterizing a biological target and a therapeutic candidate, and on initial safety and pharmacology testing in animals. This work builds the evidence needed to justify moving into humans and to design subsequent studies. IND enabling studies are about generating the data necessary to submit an IND and start human trials, but they don’t themselves initiate testing in humans; human testing begins after regulatory approval. Phase I is driven by first-in-human safety, dosing, and basic pharmacokinetics, not regulatory submission. Phase III centers on large-scale efficacy and safety outcomes to confirm benefit and risk, while post-marketing surveillance is handled in Phase IV after a drug is already approved. The description in discovery/preclinical best matches the primary objective of that stage: identify and characterize the target and candidate and assess safety and pharmacology in animals.

This question tests understanding of what each stage in the traditional drug development pipeline is aiming to achieve. In the discovery and preclinical phase, the focus is on identifying and characterizing a biological target and a therapeutic candidate, and on initial safety and pharmacology testing in animals. This work builds the evidence needed to justify moving into humans and to design subsequent studies.

IND enabling studies are about generating the data necessary to submit an IND and start human trials, but they don’t themselves initiate testing in humans; human testing begins after regulatory approval. Phase I is driven by first-in-human safety, dosing, and basic pharmacokinetics, not regulatory submission. Phase III centers on large-scale efficacy and safety outcomes to confirm benefit and risk, while post-marketing surveillance is handled in Phase IV after a drug is already approved. The description in discovery/preclinical best matches the primary objective of that stage: identify and characterize the target and candidate and assess safety and pharmacology in animals.

More practice questions